Popular Articles on Diabetesnet.com
Senseonics Eversense Continuous Glucose Monitoring System
Senseonics Inc, based in Germantown, MD, received approval from an FDA advisory panel on March 29, 2018 for its entirely implantable 90-day continuous glucose monitoring system called Eversense. The Eversense CGM system has been available in Europe since 2016 where Senseonics recently launched an extended length 180-day version. Depending on final FDA approval, Eversense may become available in the US sometime in the middle of 2018. Senseonics hopes to start studies for approval of the 180-day version this summer.
Tandem t:slim X2
Tandem’s t:slim X2 insulin pump connected to the Dexcom G5 CGM was approved by the FDA in August, 2017. The Dexcom G5 is currently the most accurate CGM on the market and will soon be followed by the G6 CGM that will have greater accuracy, no Tylenol interference, and may eventually require no calibrations. Besides the simplicity of its color touchscreen interface, the X2 is the first and only pump that allows remote software updates. This allows users to automatically upgrade the pump software without waiting for their insurance to approve a new pump body 4 to 5 years later.
Weather the Weather - MoToMove #24
Some of you might be reading this from a place where shorts and T-shirts prevail and the concept of layering to keep warm is more or less vague. We had eighteen inches of snow fall yesterday just a few blocks from the mighty Atlantic Ocean in a small one-square mile town on the New Jersey coast. Every so often we get hit with a winter nor’easter similar to a summer master-of-the-universe hurricane.
Medtronic 670G Hybrid Closed Loop System
The FDA approved the Medtronic 670G Hybrid Closed Loop System in September of 2016. It was the first device approved by the FDA that can automatically monitor blood sugars and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes.
Finding Motivation Con Brio - MoToMove #23
We all have our ways of propelling, thrusting, actuating, setting in motion, powering, joggling, driving a need or finding a desire that causes action. In other words, discovering within ourselves emotion that operates on the will and inspires us to act. Recently I ran into an old friend who had been diagnosed with T2D a couple years ago. After the initial surprise of the diagnosis and listening to recommendations from the family doctor, he decided take some action in controlling his diabetes and advocating for himself in the form of cycling.